Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ. |  |
|
|
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
REED JOHN C | EVP, Innovative Medicine, R&D | May 01 '25 | Option Exercise | 0.00 | 25,255 | 0 | 40,797 | May 05 05:10 PM | Decker Robert J | VP Corporate Controller | Feb 25 '25 | Option Exercise | 101.87 | 6,999 | 712,988 | 28,000 | Feb 26 06:42 PM | Decker Robert J | VP Corporate Controller | Feb 25 '25 | Sale | 165.88 | 6,999 | 1,160,994 | 21,001 | Feb 26 06:42 PM | Decker Robert J | Officer | Feb 25 '25 | Proposed Sale | 165.88 | 6,999 | 1,161,010 | | Feb 25 03:05 PM | Schmid Timothy | EVP, WW Chair, MedTech | Feb 14 '25 | Option Exercise | 0.00 | 2,806 | 0 | 17,904 | Feb 18 09:46 PM | Schmid Timothy | EVP, WW Chair, MedTech | Feb 15 '25 | Option Exercise | 0.00 | 1,029 | 0 | 15,501 | Feb 18 09:33 PM | Schmid Timothy | EVP, WW Chair, MedTech | Feb 14 '25 | Option Exercise | 0.00 | 1,765 | 0 | 15,111 | Feb 18 09:33 PM | Schmid Timothy | EVP, WW Chair, MedTech | Feb 13 '25 | Option Exercise | 0.00 | 499 | 0 | 13,539 | Feb 18 09:33 PM | Schmid Timothy | EVP, WW Chair, MedTech | Feb 18 '25 | Sale | 156.15 | 403 | 62,928 | 15,098 | Feb 18 09:33 PM | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Feb 15 '25 | Option Exercise | 0.00 | 607 | 0 | 91,037 | Feb 18 09:16 PM | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Feb 14 '25 | Option Exercise | 0.00 | 7,367 | 0 | 96,674 | Feb 18 09:16 PM | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Feb 13 '25 | Option Exercise | 0.00 | 651 | 0 | 89,603 | Feb 18 09:16 PM | Wolk Joseph J | Exec VP, CFO | Feb 15 '25 | Option Exercise | 0.00 | 1,971 | 0 | 6,113 | Feb 18 09:13 PM | Wolk Joseph J | Exec VP, CFO | Feb 14 '25 | Option Exercise | 0.00 | 19,330 | 0 | 20,661 | Feb 18 09:13 PM | Wolk Joseph J | Exec VP, CFO | Feb 13 '25 | Option Exercise | 0.00 | 1,779 | 0 | 1,779 | Feb 18 09:13 PM | REED JOHN C | EVP, Innovative Medicine, R&D | Feb 15 '25 | Option Exercise | 0.00 | 1,350 | 0 | 15,927 | Feb 18 09:11 PM | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Feb 15 '25 | Option Exercise | 0.00 | 1,594 | 0 | 171,110 | Feb 18 09:08 PM | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Feb 14 '25 | Option Exercise | 0.00 | 19,518 | 0 | 185,924 | Feb 18 09:08 PM | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Feb 13 '25 | Option Exercise | 0.00 | 1,302 | 0 | 167,221 | Feb 18 09:08 PM | Swanson James D. | EVP, CIO | Feb 15 '25 | Option Exercise | 0.00 | 492 | 0 | 16,762 | Feb 18 09:06 PM | Swanson James D. | EVP, CIO | Feb 14 '25 | Option Exercise | 0.00 | 5,079 | 0 | 19,739 | Feb 18 09:06 PM | Swanson James D. | EVP, CIO | Feb 13 '25 | Option Exercise | 0.00 | 447 | 0 | 15,019 | Feb 18 09:06 PM | Mulholland Kristen | EVP, Chief HR Officer | Feb 15 '25 | Option Exercise | 0.00 | 419 | 0 | 13,095 | Feb 18 09:05 PM | Mulholland Kristen | EVP, Chief HR Officer | Feb 14 '25 | Option Exercise | 0.00 | 2,608 | 0 | 14,576 | Feb 18 09:05 PM | Mulholland Kristen | EVP, Chief HR Officer | Feb 13 '25 | Option Exercise | 0.00 | 411 | 0 | 12,100 | Feb 18 09:05 PM | Forminard Elizabeth | Executive VP, General Counsel | Feb 15 '25 | Option Exercise | 0.00 | 961 | 0 | 10,321 | Feb 18 09:03 PM | Forminard Elizabeth | Executive VP, General Counsel | Feb 14 '25 | Option Exercise | 0.00 | 2,203 | 0 | 11,366 | Feb 18 09:03 PM | Forminard Elizabeth | Executive VP, General Counsel | Feb 13 '25 | Option Exercise | 0.00 | 651 | 0 | 8,991 | Feb 18 09:03 PM | Duato Joaquin | CEO and Chairman of the Board | Feb 15 '25 | Option Exercise | 0.00 | 3,682 | 0 | 397,525 | Feb 18 09:02 PM | Duato Joaquin | CEO and Chairman of the Board | Feb 14 '25 | Option Exercise | 0.00 | 24,335 | 0 | 415,205 | Feb 18 09:02 PM | Duato Joaquin | CEO and Chairman of the Board | Feb 13 '25 | Option Exercise | 0.00 | 3,470 | 0 | 392,498 | Feb 18 09:02 PM | Decker Robert J | VP Corporate Controller | Feb 15 '25 | Option Exercise | 0.00 | 339 | 0 | 20,116 | Feb 18 09:01 PM | Decker Robert J | VP Corporate Controller | Feb 14 '25 | Option Exercise | 0.00 | 2,201 | 0 | 21,373 | Feb 18 09:01 PM | Decker Robert J | VP Corporate Controller | Feb 13 '25 | Option Exercise | 0.00 | 312 | 0 | 19,285 | Feb 18 09:01 PM | Broadhurst Vanessa | EVP, Global Corp Affairs | Feb 15 '25 | Option Exercise | 0.00 | 492 | 0 | 21,839 | Feb 18 08:58 PM | Broadhurst Vanessa | EVP, Global Corp Affairs | Feb 14 '25 | Option Exercise | 0.00 | 4,740 | 0 | 24,591 | Feb 18 08:58 PM | Broadhurst Vanessa | EVP, Global Corp Affairs | Feb 13 '25 | Option Exercise | 0.00 | 408 | 0 | 20,242 | Feb 18 08:58 PM | Duato Joaquin | CEO and Chairman of the Board | Feb 07 '25 | Option Exercise | 100.06 | 126,369 | 12,644,482 | 489,671 | Feb 11 07:43 PM | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Feb 07 '25 | Option Exercise | 100.06 | 32,762 | 3,278,166 | 115,028 | Feb 11 07:42 PM | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Feb 07 '25 | Option Exercise | 100.06 | 58,504 | 5,853,910 | 213,355 | Feb 11 07:41 PM | Wolk Joseph J | Exec VP, CFO | Feb 07 '25 | Option Exercise | 100.06 | 13,015 | 1,302,281 | 13,015 | Feb 11 07:40 PM | Wolk Joseph J | Exec VP, CFO | Feb 07 '25 | Sale | 153.89 | 13,015 | 2,002,878 | 0 | Feb 11 07:40 PM | Wolk Joseph J | Officer | Feb 07 '25 | Proposed Sale | 153.89 | 13,015 | 2,002,924 | | Feb 07 01:27 PM | WEINBERGER MARK A | Director | Dec 12 '24 | Buy | 147.22 | 1,000 | 147,220 | 1,000 | Dec 12 05:27 PM | Hait William | Former Officer | Dec 04 '24 | Proposed Sale | 149.90 | 25,742 | 3,858,598 | | Dec 04 01:25 PM | Decker Robert J | VP Corporate Controller | Aug 30 '24 | Option Exercise | 100.06 | 5,635 | 563,838 | 24,608 | Sep 03 04:48 PM | Decker Robert J | VP Corporate Controller | Aug 30 '24 | Sale | 165.06 | 5,635 | 930,113 | 18,973 | Sep 03 04:48 PM | Decker Robert J | Officer | Aug 30 '24 | Proposed Sale | 165.06 | 5,635 | 930,113 | | Aug 30 03:51 PM |
|